SCHEDULE 13G/A: Millennium Management Discloses Passive 0.7% Stake in Pacira BioSciences
Beneficial Ownership Disclosure
Millennium Management LLC, along with its affiliates and Israel A. Englander, has filed an amended Schedule 13G disclosing a passive beneficial ownership of 0.7% in Pacira BioSciences, Inc.'s common stock as of March 31, 2025.
Summary
- Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander collectively beneficially own 345,625 shares of Pacira BioSciences, Inc. common stock.
- This ownership represents 0.7% of the outstanding common stock of Pacira BioSciences, Inc.
- The reporting persons hold shared voting power and shared dispositive power over all 345,625 shares.
- The filing indicates that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.
- The filing is an Amendment No. 1 to a previous Schedule 13G, with the event date requiring filing being March 31, 2025.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing (Schedule 13G Amendment) disclosing passive ownership. It contains no positive or negative operational or financial news, thus the sentiment is neutral.
Future Outlook
N/A
Industry Context
This Schedule 13G filing indicates a passive investment by a significant institutional investor, Millennium Management, in Pacira BioSciences. Such filings are routine disclosures required by the SEC when an entity acquires more than 5% of a company's stock (initial filing) or when their ownership changes significantly (amendment), and they intend to hold the shares passively without seeking to influence control. For a stake below 5% (0.7% in this case), it's likely an amendment to a previously filed 13G, indicating a change in their holding, possibly a reduction or a re-categorization of their stake.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake in the company, which can offer some insight into institutional interest, though the stake is small (0.7%).
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement (reporting period end date). |
| 04/17/2025 | Date of signing for Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, and date of the Joint Filing Agreement. |
Keywords
Pacira BioSciences, Millennium Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.